Oruka Therapeutics Prices $700M Public Offering at $72.50 Per Share
Oruka Therapeutics (ORKA) has priced its upsized public offering of 9.66 million shares at $72.50 each, generating approximately $700.4 million in gross proceeds. The underwriters have a 30-day option to purchase up to an additional 1.45 million shares.
Tickers: $ORKA
Topics: equity financing funding public offering